$19.830
-0.759 (-3.83%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
NewAmsterdam Pharma Company NV (NAMS) Moving Averages Convergence Divergence (MACD) indicator is -1.13, suggesting NAMS is Strong sell.
NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 22.25, while NewAmsterdam Pharma Company NV (NAMS) share price is $—, making it Sell.
NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 24.90, while NewAmsterdam Pharma Company NV (NAMS) share price is $—, making it Sell.
Technical Analysis for NAMS
AI Technical NAMSAs of 2026-10-17, the technical board for NewAmsterdam Pharma Company NV (NAMS) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $19.83 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 31.7, MACD stands at -1.125 (Sell), Stochastic %K stands at 10.349 (Buy), Stochastic %D stands at 8.814 and CCI stands at -141.271 (Buy).
NAMS trades below the 60-day SMA (24.90) and below the 200-day SMA (30.47). Immediate resistance sits at Classic R1 23.16, then R2 25.13. Support sits at Classic S1 19.40, then S2 17.61.
NewAmsterdam Pharma Company NV (NAMS) Support & Resistance Level
NewAmsterdam Pharma Company NV (NAMS) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 31.700 |
| STOCHk_14_3_3 | 10.349 |
| STOCHd_14_3_3 | 8.814 |
| CCI_20 | -141.271 |
| AO_5_34 | -2.208 |
| MOM_10 | -3.370 |
| MACD_12_26_9 | -1.125 |
NewAmsterdam Pharma Company NV (NAMS) Relative Strength Index (RSI_14) is 31.700, creating a Neutral signal.
NewAmsterdam Pharma Company NV (NAMS) Stochastic %K is 10.349, creating a Buy signal.
NewAmsterdam Pharma Company NV (NAMS) Stochastic %D is 8.814, creating a Buy signal.
NewAmsterdam Pharma Company NV (NAMS) CCI_20 is -141.271, creating a Buy signal.
NewAmsterdam Pharma Company NV (NAMS) Awesome Oscillator (AO) is -2.208, creating a Sell signal.
NewAmsterdam Pharma Company NV (NAMS) Momentum (MOM) is -3.370, creating a Sell signal.
NewAmsterdam Pharma Company NV (NAMS) Moving Average Convergence Divergence (MACD) is -1.125, creating a Sell signal.
NewAmsterdam Pharma Company NV (NAMS) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 20.380 | Sell |
| MA_10 | 21.194 | Sell |
| MA_20 | 22.245 | Sell |
| MA_60 | 24.900 | Sell |
| MA_200 | 30.468 | Sell |
| MA_250 | 31.764 | Sell |
NewAmsterdam Pharma Company NV (NAMS) 5-Day simple moving average is 20.380, while NewAmsterdam Pharma Company NV (NAMS) share price is $, making it a Sell.
NewAmsterdam Pharma Company NV (NAMS) 10-Day simple moving average is 21.194, while NewAmsterdam Pharma Company NV (NAMS) share price is $, making it a Sell.
NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 22.245, while NewAmsterdam Pharma Company NV (NAMS) share price is $, making it a Sell.
NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 24.900, while NewAmsterdam Pharma Company NV (NAMS) share price is $, making it a Sell.
NewAmsterdam Pharma Company NV (NAMS) 200-Day simple moving average is 30.468, while NewAmsterdam Pharma Company NV (NAMS) share price is $, making it a Sell.
NewAmsterdam Pharma Company NV (NAMS) 250-Day simple moving average is 31.764, while NewAmsterdam Pharma Company NV (NAMS) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.